CaseTrail

Amgen Inc. v. Sanofi

598 U.S. 594 · Decided May 18, 2023 · Supreme Court of the United States

Record summary. This page is generated from the Supreme Court Database’s coded data about the case. It describes who decided what, not the Court’s reasoning. Read the opinion itself before relying on it. Not legal advice.

At a glance

Amgen Inc. v. Sanofi was decided on May 18, 2023 unanimously (9–0). The Court affirmed the lower court's decision. Justice Neil M. Gorsuch wrote the opinion of the Court. SCDB classifies its main issue as “Patents” in the Economic Activity area.

Read the opinion

Case details

Citations
598 U.S. 594 · 143 S. Ct. 1243 · 215 L. Ed. 2d 537 · 2023 U.S. LEXIS 2058
Docket number
21-757
Decided
May 18, 2023
Argued
March 27, 2023
Court era
Roberts Court
Decision type
Opinion of the Court (orally argued)
Disposition
Affirmed
Outcome for petitioner
The petitioning party did not receive a favorable disposition
Vote
9–0 (unanimous)
Majority opinion
Neil M. Gorsuch
Opinion assigned by
John G. Roberts Jr.
How the case arrived
Certiorari
Issue (SCDB)
Patents
Legal provision
Patent Act
Type of law
Infrequently litigated statute
Decision direction (SCDB)
Liberal what this means

How the Justices voted

Full case caption

Amgen Inc. v. Sanofi

SCDB identifiers: case 2022-046, docket 2022-046-01.

Other cases on “Patents”

See all

Same Term, same area (Economic Activity)

See all

Source: Supreme Court Database, 2026 Release 01 (data file dated September 8, 2026). Imported into CaseTrail November 5, 2026. Coverage: decisions from the 1946 through 2025 Terms. Methodology · Report an error